- Roche Climbs As Once-Daily Weight Loss Pill Shows Promise Forbes
- Lilly — And A Host Of Obesity Stocks — Skid On Roche’s Test Investor’s Business Daily
- For companies in the Ozempic-fueled weight-loss economy, it’s survival of the fittest Los Angeles Times
Brought to you by Google News. Read the rest of the article here